Dr. Blanchard joined the Board of Directors in November 2019 following Daré’s acquisition of Microchips Biotech, a company for which Dr. Blanchard served as President and CEO from 2014 through the closing of the transaction with Daré. Dr. Blanchard currently serves as President and CEO of Anika Therapeutics, a publicly-traded biotech and medical devices company that is leveraging proprietary regenerative and restoration therapies. Dr. Blanchard previously served on the boards of directors of Neuronetics and SeaSpine Holdings and on the boards of several private equity and venture backed companies. Her prior experience includes Senior Vice President, Chief Scientific Officer and General Manager of Biologics at Zimmer, Inc., responsible for Global R&D, Quality, Regulatory and Clinical Affairs, Health Economics and the Regenerative Medicine Business. Dr. Blanchard received her MS and PhD in Materials Science and Engineering from the University of Texas at Austin and her BS in Ceramic Engineering from Alfred University. She is also a member of the National Academy of Engineering.